Professor Gino Martini, Chair in Pharmaceutical Innovation, Department of Pharmacy & Forensic Science, King's College London.
Roger M. Perlmutter: 'The free flow of scientific talent in and out of the UK is incredibly important'Subscription
Roger M. Perlmutter is the executive vice president of Merck Sharp & Dohme, and president of MSD Research Laboratories. On a visit to London, he caught up with Gino Martini, chief scientist at the Royal Pharmaceutical Society, for a chat about the future of pharmaceutical research and his experiences of the industry.
With great sadness we learned of the passing of Peter Hylands, formerly head of the Institute of Pharmaceutical Science (IPS) at King’s College London (KCL). Peter was an internationalist and pioneer in the field of natural product chemistry: one of the first to recognise the importance of nuclear magnetic resonance spectroscopy to the structural elucidation of natural products. He was a leader in the application of proteomics and metabolomics for quality assurance of medicines derived
Gino Martini, a representative of the RPS Pharmaceutical Sciences External Advisory Panel and recently appointed chair of the RPS Industrial Pharmacy Forum, discusses the increasingly important impact of personalised medicines on pharmacists and other healthcare professionals.
Recent blog posts
Patients require different combinations of drugs at different doses. Gino Martini explains how ‘polypills’ may enable patients to take one tablet containing the medicines and doses appropriate for them.